Effect of Treatment with 5-Ethyl-2′-Deoxyuridine on Herpes Simplex Virus Encephalitis in Normal and Immunosuppressed Mice
- 1 November 1978
- journal article
- research article
- Published by American Society for Microbiology in Antimicrobial Agents and Chemotherapy
- Vol. 14 (5), 743-748
- https://doi.org/10.1128/aac.14.5.743
Abstract
5-Ethyl-2′-deoxyuridine (5-ethyl-dUrd), an analog of thymidine, was evaluated for its capacity to inhibit herpes simplex virus (HSV) replication in vitro and in vivo. The 50% effective dose concentration of 5-ethyl-dUrd for HSV types 1 and 2 (HSV-1 and -2) cultured in Vero cells was 6 and 9 μg/ml, respectively. Levels of 5-ethyl-dUrd 14-fold in excess of the 50% effective dose for HSV-1 did not inhibit the formation of confluent monolayers by Vero cells, suggesting that the compound was not cytotoxic or inhibitory for mammalian cells. In vivo studies showed that 5-ethyl-dUrd was effective in significantly reducing mortality when administered to young adult mice after subcutaneous infection with HSV-2. Intraperitoneal and intravenous inoculation of drug (250 mg/kg per day) resulted in a 50% survivor rate at 15 days. Comparative studies with adenine arabinoside at 250 mg/kg per day gave a 40% survivor rate. Intramuscular injection of 5-ethyl-dUrd at a concentration as high as 2,000 mg/kg per day for 10 days was well tolerated by uninfected animals, and HSV-2-infected mice treated at this dosage had a 100% survival rate. Treatment with 5-ethyl-dUrd at a concentration of 500 mg/kg per day significantly increased the mean survival times of HSV-1- and HSV-2-infected mice immunosuppressed by irradiation; however, the fatal course of the infection was not altered. Assay for virus in tissues showed that 5-ethyl-dUrd treatment delayed progression of the infection into the central nervous system, indicating suppression of virus replication in the tissues.This publication has 24 references indexed in Scilit:
- Adenine Arabinoside Therapy of Biopsy-Proved Herpes Simplex EncephalitisNew England Journal of Medicine, 1977
- COMPARATIVE ANIMAL TOXICOLOGY OF VIDARABINE AND ITS 5'-MONOPHOSPHATEAnnals of the New York Academy of Sciences, 1977
- Failure of 5-ethyl-2′-deoxyuridine to induce oncogenic RNA (oncorna) viruses in Fischer rat embryo cells and in Balb/3T3 mouse cellsBiochemical Pharmacology, 1976
- Toxicity of Adenine Arabinoside in HumansThe Journal of Infectious Diseases, 1976
- Antiviral activity of 5-ethyl pyrimidine deoxynucleosidesBiochemical Pharmacology, 1975
- Effects of Adenine Arabinoside on Cellular Immune Mechanisms in HumansAntimicrobial Agents and Chemotherapy, 1975
- Invasion of the Central Nervous System by Herpes Simplex Virus Type 1 after Subcutaneous Inoculation of Immunosuppressed MiceThe Journal of Infectious Diseases, 1975
- Notes. A Nonmutagenic Thymidine Analog with Antiviral Activity. 5-EthyldeoxyuridineJournal of Medicinal Chemistry, 1969
- Immunobiological Studies with the Virostatics 5-Ethyl-2’-deoxyuridine (EDU) and 1-AlIyl-3,5-diethyl-6-chlorouraciI (ACIU)Chemotherapy, 1969
- Keine Mutationsauslösung durch 5-Äthyl-2′-desoxyuridin (ÄDU) bei Drosophila melanogasterRadiation and Environmental Biophysics, 1968